Biogen to acquire UK gene therapy company Nightstar Therapeutics for $800m
Biogen acquisition of Nightstar Therapeutics : US biotech company Biogen has signed a deal of $800 million to acquire Nightstar
Continue readingCoverage of Global Pharma Industry News
Biogen acquisition of Nightstar Therapeutics : US biotech company Biogen has signed a deal of $800 million to acquire Nightstar
Continue readingRoche acquisition of Spark Therapeutics : Swiss pharma giant Roche has signed an all-cash deal worth $4.3 billion to acquire
Continue readingUS pharma company Xeris Pharmaceuticals announced that it has started dosing in a phase 2 trial with its ready-to-use, room
Continue readingTecentriq FDA approval : Roche subsidiary Genetech has bagged a new approval from the US Food and Drug Administration (FDA)
Continue readingRegeneron Pharmaceuticals and Sanofi have secured approval for Praluent (alirocumab) for a new indication from the European Commission (EC), which
Continue readingBoston Scientific said that its LUMINIZE Radiofrequency (RF) Balloon Catheter (LUMINIZE RF Balloon Catheter), which is intended to be used
Continue readingStryker acquisition of OrthoSpace : US medical technologies firm Stryker has acquired an Israeli medical device company OrthoSpace in an
Continue readingBiotronik has bagged US FDA approval for its high-voltage cardiac rhythm management (CRM) devices – Acticor and Rivacor range of
Continue readingBlackstone acquisition of AYUMI : Global investment firm Blackstone said that private equity funds managed by it will acquire Japanese
Continue readingX4 Pharmaceuticals has completed its previously announced merger with Arsanis in a move to create a late-stage biopharma company focused
Continue reading